LEGN logo

Legend Biotech Corporation (LEGN) EBITDA

annual EBITDA:

-$286.21M+$135.55M(+32.14%)
December 31, 2024

Summary

  • As of today (September 14, 2025), LEGN annual EBITDA is -$286.21 million, with the most recent change of +$135.55 million (+32.14%) on December 31, 2024.
  • During the last 3 years, LEGN annual EBITDA has risen by +$93.87 million (+24.70%).
  • LEGN annual EBITDA is now -2144.66% below its all-time high of $14.00 million, reached on December 1, 2017.

Performance

LEGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

quarterly EBITDA:

-$113.72M-$24.85M(-27.96%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LEGN quarterly EBITDA is -$113.72 million, with the most recent change of -$24.85 million (-27.96%) on June 30, 2025.
  • Over the past year, LEGN quarterly EBITDA has dropped by -$106.61 million (-1497.89%).
  • LEGN quarterly EBITDA is now -316.78% below its all-time high of $52.46 million, reached on December 31, 2024.

Performance

LEGN quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

TTM EBITDA:

-$260.04M-$106.61M(-69.48%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LEGN TTM EBITDA is -$260.04 million, with the most recent change of -$106.61 million (-69.48%) on June 30, 2025.
  • Over the past year, LEGN TTM EBITDA has dropped by -$17.05 million (-7.01%).
  • LEGN TTM EBITDA is now -2101.52% below its all-time high of -$11.81 million, reached on March 31, 2019.

Performance

LEGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

LEGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.1%-1497.9%-7.0%
3 y3 years+24.7%+40.6%+42.1%
5 y5 years-117.2%+15.6%+3.0%

LEGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+34.9%-316.8%+39.8%-129.8%+47.5%
5 y5-year-117.2%+34.9%-316.8%+40.6%-129.8%+47.5%
alltimeall time-2144.7%+34.9%-316.8%+40.6%-2101.5%+47.5%

LEGN EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$113.72M(+28.0%)
-$260.04M(+69.5%)
Mar 2025
-
-$88.87M(-269.4%)
-$153.44M(+35.6%)
Dec 2024
-$286.21M(-32.1%)
$52.46M(-147.7%)
-$113.16M(-62.4%)
Sep 2024
-
-$109.91M(+1444.3%)
-$301.26M(+24.0%)
Jun 2024
-
-$7.12M(-85.4%)
-$243.00M(-42.8%)
Mar 2024
-
-$48.59M(-64.2%)
-$424.79M(-11.1%)
Dec 2023
-$421.76M(-4.1%)
-$135.64M(+162.6%)
-$477.87M(+2.1%)
Sep 2023
-
-$51.65M(-72.7%)
-$467.85M(-5.0%)
Jun 2023
-
-$188.91M(+85.8%)
-$492.64M(-0.5%)
Mar 2023
-
-$101.68M(-19.1%)
-$495.17M(+16.6%)
Dec 2022
-$439.66M(+15.7%)
-$125.61M(+64.3%)
-$424.57M(+5.1%)
Sep 2022
-
-$76.45M(-60.1%)
-$403.96M(-10.1%)
Jun 2022
-
-$191.43M(+515.9%)
-$449.20M(+28.6%)
Mar 2022
-
-$31.08M(-70.4%)
-$349.31M(-15.4%)
DateAnnualQuarterlyTTM
Dec 2021
-$380.08M(+72.5%)
-$105.01M(-13.7%)
-$412.79M(+12.1%)
Sep 2021
-
-$121.69M(+32.9%)
-$368.39M(+17.4%)
Jun 2021
-
-$91.53M(-3.2%)
-$313.67M(-12.1%)
Mar 2021
-
-$94.56M(+56.0%)
-$356.93M(+16.5%)
Dec 2020
-$220.32M(+67.2%)
-$60.61M(-9.5%)
-$306.31M(-0.3%)
Sep 2020
-
-$66.96M(-50.3%)
-$307.30M(+14.6%)
Jun 2020
-
-$134.79M(+206.7%)
-$268.04M(+65.8%)
Mar 2020
-
-$43.95M(-28.7%)
-$161.70M(+24.8%)
Dec 2019
-$131.79M(+858.5%)
-$61.60M(+122.3%)
-$129.57M(+90.6%)
Sep 2019
-
-$27.71M(-2.6%)
-$67.97M(+68.8%)
Jun 2019
-
-$28.45M(+140.8%)
-$40.26M(+240.8%)
Mar 2019
-
-$11.81M
-$11.81M
Dec 2018
-$13.75M(-198.2%)
-
-
Dec 2017
$14.00M
-
-

FAQ

  • What is Legend Biotech Corporation annual EBITDA?
  • What is the all time high annual EBITDA for Legend Biotech Corporation?
  • What is Legend Biotech Corporation annual EBITDA year-on-year change?
  • What is Legend Biotech Corporation quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Legend Biotech Corporation?
  • What is Legend Biotech Corporation quarterly EBITDA year-on-year change?
  • What is Legend Biotech Corporation TTM EBITDA?
  • What is the all time high TTM EBITDA for Legend Biotech Corporation?
  • What is Legend Biotech Corporation TTM EBITDA year-on-year change?

What is Legend Biotech Corporation annual EBITDA?

The current annual EBITDA of LEGN is -$286.21M

What is the all time high annual EBITDA for Legend Biotech Corporation?

Legend Biotech Corporation all-time high annual EBITDA is $14.00M

What is Legend Biotech Corporation annual EBITDA year-on-year change?

Over the past year, LEGN annual EBITDA has changed by +$135.55M (+32.14%)

What is Legend Biotech Corporation quarterly EBITDA?

The current quarterly EBITDA of LEGN is -$113.72M

What is the all time high quarterly EBITDA for Legend Biotech Corporation?

Legend Biotech Corporation all-time high quarterly EBITDA is $52.46M

What is Legend Biotech Corporation quarterly EBITDA year-on-year change?

Over the past year, LEGN quarterly EBITDA has changed by -$106.61M (-1497.89%)

What is Legend Biotech Corporation TTM EBITDA?

The current TTM EBITDA of LEGN is -$260.04M

What is the all time high TTM EBITDA for Legend Biotech Corporation?

Legend Biotech Corporation all-time high TTM EBITDA is -$11.81M

What is Legend Biotech Corporation TTM EBITDA year-on-year change?

Over the past year, LEGN TTM EBITDA has changed by -$17.05M (-7.01%)
On this page